Steven H. Bernstein

Steven H. Bernstein

Director Técnico/Científico/I+D en 2SEVENTY BIO, INC. .

Health Technology
Consumer Services
Health Services

Perfil

Steven H.
Bernstein
is currently the Chief Medical Officer at 2seventy Bio, Inc. He previously worked as the Chairman of Immuno-Oncology Translational Research at Bristol Myers Squibb Co., a Professor of Medicine and Co-Director of Hematological at James P.
Wilmot Cancer Center, a Member of Lymphoma Working Group at SWOG, and the Chief Translational Officer at Turnstone Biologics Corp.
He received his undergraduate degree from Brandeis University and his doctorate from New York University School of Medicine.

Cargos activos de Steven H. Bernstein

EmpresasCargoInicio
2SEVENTY BIO, INC. Director Técnico/Científico/I+D 14/02/2022
Todos los cargos activos de Steven H. Bernstein

Antiguos cargos conocidos de Steven H. Bernstein.

EmpresasCargoFin
Corporate Officer/Principal -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
James P. Wilmot Cancer Center Corporate Officer/Principal -
TURNSTONE BIOLOGICS CORP. Director Técnico/Científico/I+D -
Ver el detalle de la experiencia de Steven H. Bernstein.

Formación de Steven H. Bernstein.

Brandeis University Undergraduate Degree
New York University School of Medicine Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Steven H. Bernstein.

Relaciones

15

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
2SEVENTY BIO, INC.

Health Technology

TURNSTONE BIOLOGICS CORP.

Health Technology

BRISTOL-MYERS SQUIBB COMPANY

Health Technology

Empresas privadas2
James P. Wilmot Cancer Center

Health Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Steven H. Bernstein